| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.23 | 0.001 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.23 | 0.001 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.002 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |